Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 20/20 | 0.98 |
| ▸ | CCR5 | P51681 | 1/20 | 0.98 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.98 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30241543 | 0.99 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL30241535 | 0.99 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL30241522 | 0.99 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL358731 | 0.99 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL22653557 | 0.98 | CCR4 (0.98) | CCR4CCR5FFAR4SLCO1B1 | |
| Potassium SCHEMBL30522127 | 0.98 | CCR4 (0.98) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL30522123 | 0.98 | CCR4 (0.98) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL358278 | 0.94 | CCR4 (0.90) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL186736 | 0.93 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL10235136 | 0.92 | CCR4 (0.86) | CCR4CCR5FFAR4SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3738962-B1 | SALTS OF A COMPOUND AND USE THEREOF | MEDSPRING INTERNATIONAL LTD (CN) | 2023-08-02 | — | — | EP | disclosed |
| CN-110028501-B | Compound and preparation method and application thereof | 迈德欣国际有限公司 | 2022-02-22 | — | — | CN | disclosed |
| US-20210078985-A1 | COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | MEDSPRING INTERNATIONAL LIMITED (CN) | 2021-03-18 | — | — | US | disclosed |
| EP-3738962-A1 | COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Medspring International Limited (CN) | 2020-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210078985-A1 | COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | CCR4, CCR1, CCL11 | CCR4 1/4885CCR5 14/4885FFAR4 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.